Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer

Accumulating data suggests that the initiation and progression of human breast tumors is fueled by a rare subpopulation of tumor cells, termed breast tumor-initiating cells (BTIC), which resist radiotherapy and chemotherapy. Consequently, therapies that abrogate BTIC activity are needed to achieve d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallett, Robin M., Girgis-Gabardo, Adele, Gwynne, William D., Giacomelli, Andrew O., Bisson, Jennifer N.P., Jensen, Jeremy E., Dvorkin-Gheva, Anna, Hassell, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288174/
https://www.ncbi.nlm.nih.gov/pubmed/27447971
http://dx.doi.org/10.18632/oncotarget.10614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288174/
https://www.ncbi.nlm.nih.gov/pubmed/27447971
http://dx.doi.org/10.18632/oncotarget.10614

Ejemplares similares